Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

RTTNews | Před 700 dny
Nektar, Cellular Biomedicine Enter New Clinical Study Collaboration

(RTTNews) - Nektar Therapeutics (NKTR) announced Wednesday that it has entered into a new clinical study collaboration with Cellular Biomedicine Group Inc. (CBMG).

The study will evaluate Nektar's NKTR-255, a novel interleukin-15 (IL-15) receptor agonist, in combination with CBMG's C-TIL051, a tumor-infiltrating lymphocyte (TIL) therapy, in advanced non-small cell lung cancer (NSCLC) patients that are relapsed or refractory to anti-PD-1 therapy.

Preclinical and early clinical data suggest that IL-15 can improve proliferation and persistence of cellular therapies including TIL, TCR, and CAR-T therapies to increase specific anti-tumor activity.

Under the new collaboration, CBMG will add NKTR-255 to its ongoing CBMG-sponsored Phase 1 clinical trial evaluating C-TIL051 in NSCLC patients who have relapsed on or were refractory to anti-PD-1 therapy.

The study is expected to enroll a total of 20 patients. Nektar will contribute NKTR-255 supply for the study. Nektar and CBMG will each maintain existing global rights to their respective investigational medicines.

For More Such Health News, visit rttnews.com

read more
European Stocks Close On Mixed Note

European Stocks Close On Mixed Note

European stocks turned in a mixed performance on Wednesday as investors largely stayed cautious, looking ahead to chipmaker Nvidia's quarterly earnings announcement, and continuing to assess the political situation in France.
RTTNews | Před 49 minutami
Euro Falls Amid Political Uncertainty

Euro Falls Amid Political Uncertainty

The euro weakened against other major currencies in the European session on Wednesday, as trader's concern about the collapse of France's government.
RTTNews | Před 5 h 5 min
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian shares are likely to open on a positive note on Wednesday, riding on strong earnings from Royal Bank of Canada and National Bank of Canada. Weak commodity prices and concerns on the geopolitical and tariffs front may weigh limit market's upside.
RTTNews | Před 5 h 31 min
European Stocks Turning In Mixed Performance

European Stocks Turning In Mixed Performance

European stocks are turning in a mixed performance on Wednesday as political uncertainty in France, and a lack of any significant positive triggers render the mood cautious. Investors are also awaiting earnings updates from AI major NVIDIA.
RTTNews | Před 5 h 57 min
FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower

FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower

U.K. stocks are somewhat subdued in lackluster trade on Wednesday as investors remain a bit reluctant to make significant moves due to a lack of triggers. The benchmark FTSE 100 was at 9,266.25 a little before noon, up 0.45 points over previous close.
RTTNews | Před 6 h 47 min
CAC 40 Advances After Recent Losses

CAC 40 Advances After Recent Losses

Despite the uncertainty on the political front, the French market is up in positive territory on Wednesday due largely to some bargain hunting at several counters after two successive days of declines. Investors are also looking ahead to AI giant Nvidia's earnings updates.
RTTNews | Před 7 h 2 min
DAX Remains Weak Despite Paring Some Early Losses

DAX Remains Weak Despite Paring Some Early Losses

German stocks are down in negative territory in cautious trade on Wednesday amid political uncertainty in France ahead of a confidence vote early next month, and anxiety ahead of Nvidia's earnings for clues on the AI trade.
RTTNews | Před 7 h 18 min